Professor Christopher Hawkey

Professor Christopher Hawkey

Queens Medical Centre Campus, Derby Road, Nottingham, NG7 2UH

+44 115 823 1033 View full bio
Professor of Gastroenterology

Christopher Hawkey is Professor of Gastroenterology at the Nottingham Digestive Diseases Centre. His main interests are in the field of non-steroid anti-inflammatory drugs and inflammatory bowel disease. In both areas his approach is to try to identify targets in small exploratory studies and then evaluate them in large and/or outcomes studies.

Research Summary


  • Non-steroidal anti-inflammatory drugs
  • Inflammatory bowel disease
  • Chemoprophylaxis of gastrointestinal cancers


  • Clinical trials including: Phase I assessments, particularly by endoscopy in volunteers Small proof of concept Phase II trials Clinical trial design, including Outcome studies
  • Ex-vivo translational research
  • Current research projects
  • Target Outcomes Study of selective vs non-selective NSAIDs
Clinical trial: a randomized trial of early endoscopy, Helicobacter pylori testing and empirical the
Beliefs about personal control and self-management in 30-40 year olds living with Inflammatory Bowel
Comparison of High Definition with Standard White Light Endoscopy for Detection of Dysplastic Lesion
Predictors of gastroduodenal erosions in patients taking low-dose aspirin
A Novel Composite Endpoint to Evaluate the Gastrointestinal Effects of NSAID Through the Entire GI T
Clinical Effects of a Topically Applied Toll-like Receptor 9 Agonist in Active Moderate-to-Severe Ul
Drugs that cause and heal peptic ulcer disease
Living with Crohn’s disease: an exploratory cross-sectional qualitative study into decision-making a
Guest authorship, mortality reporting, and integrity in rofecoxib studies
NSAIDs and aspirin: notorious or FAMOUS?
Rofecoxib and Clinically Significant Gastrointestinal Events
Safer NSAID strategies: consensus or contentious?
Autologous stem cell transplantation for Crohn’s disease (ASTIC) Trial:  Early report of toxicity an
Less small-bowel injury with lumiracoxib compared with naproxen plus omeprazole
Clinical trial: comparison of the gastrointestinal safety of lumiracoxib with traditional nonselecti
Esomeprazole for the Management of Upper Gastrointestinal Symptoms in Patients Who Require NSAIDs A
Clinical and endoscopic improvement following haemopoietic stem cell transplantation on behalf of th
Gastroduodenal toxicity of low-dose acetylsalicylic acid: a comparison with non-steroidal anti-infla
Methodology of a large prospective, randomised, open, blinded endpoint streamlined safety study of c
Narrow band imaging for characterization of high grade dysplasia and specialized intestinal metaplas
Meta-analysis: the diagnostic yield of chromoendoscopy for detecting dysplasia in patients with colo
Feasibility of reducing aspirin-associated ulcer bleeding by Helicobacter pylori eradication
Efficacy of New Playback Functions at Reducing Small-Bowel Wireless Capsule Endoscopy Reading Times
Optical Microangiography: High-Definition Magnification Colonoscopy with Narrow Band Imaging (NBI) f